MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2023 International Congress

    Multimodal neuroimaging of Parkinson’s disease with diffusion tensor imaging (DTI) and dopamine transporter (DAT) positron emission tomography

    P. Honhar, S. Tinaz, M. Dias, R. Comley, S. Finnema, R. Carson, D. Scheinost, D. Matuskey (New Haven, USA)

    Objective: The main aims of this study were to characterize brain microstructure alterations in a cross-sectional cohort of Parkinson’s disease (PD) with DTI and assess…
  • 2023 International Congress

    Functional connectivity fingerprints in Parkinson’s disease patients with hallucinations

    S. Stampacchia, F. Bernasconi, J. Potheegadoo, J. Pagonabarraga, J. Kulisevsky, D. van Deville, E. Amico, O. Blanke (Geneve, Switzerland)

    Objective: Investigate functional connectivity (FC) fingerprints of Minor Hallucinations (MH) in Parkinson’s Disease (PD). Background: MHs occur at the early stages of Parkinson’s disease in…
  • 2023 International Congress

    Caregiver burden in Parkinson disease: an updated scoping review

    J. Corcoran, W. Aamodt, S. Seshadri, M. Mirham, A. Job, S. Lettenberger, B. Kluger (Rochester, USA)

    Objective: We performed a scoping review to describe caregiver burden in Parkinson disease (PD) and build on the evidence provided by Mosely at al. [1]…
  • 2023 International Congress

    Levodopa-entacapone-carbidopa intestinal gel infusion for Parkinson’s disease: An analysis of data collected from the Swedish national register of Parkinson’s disease.

    M. öthman, P. Odin, F. Bergquist, A. Johansson, R. Constantinescu, M. Scharfenort, H. Widner, D. Nyholm (Uppsala, Sweden)

    Objective: To investigate efficacy, tolerability, and safety of levodopa-entacapone-carbidopa intestinal gel (LECIG) in Parkinson’s disease. Background: LECIG was introduced in 2019. The approval was based…
  • 2023 International Congress

    Impact of non-motor fluctuations on QOL in patients with Parkinson’s disease

    A. Kakimoto, M. Kawazoe, K. Kurihara, T. Mishima, Y. Tuboi (Fukuoka, Japan)

    Objective: To investigate the impact of non-motor fluctuations for QOL in patients with Parkinson's disease (PwPD) using a nine-item wearing-off questionnaire (WOQ-9). Background: Long-term levodopa…
  • 2023 International Congress

    Dynamic assessment of levels of depression and anxiety impairment in Parkinson’s disease

    O. Naimov, R. Matmurodov (Tashkent, Uzbekistan)

    Objective: To dynamic assessment of depression and anxiety disorders in Parkinson's disease. Background: One of the most common nonmotor disturbances in Parkinson's disease (PD) is…
  • 2023 International Congress

    Correlation between levels of plasma neurofilament light chain and freezing of gait in Parkinson’s disease

    Y. Zhu, X. Yang, H. Ren, A. Pang (Kunming, China)

    Objective: This study evaluated the correlation between neurofilament light chain (NfL) and freezing of gait (FOG) in Parkinson's disease (PD). Background: PD patients frequently experience…
  • 2023 International Congress

    Empowerment of People with Parkinson`s disease: development, testing and evaluation of a cross-sectoral, intervention-based self-management program

    T. Thomsen, S. Skovbølling, M. Møller, V. Grønlund, M. Brønden, B. Biering-Sørensen (Glostrup, Denmark)

    Objective: The overall purpose of this study is to develop, test and evaluate the results of a self-management program targeted PwP with the aim of…
  • 2023 International Congress

    Beta is jumping the queue: Temporal overlap of beta desynchronization and synchronization during rapid movement changes

    L. Winkler, M. Butz, A. Sharma, J. Vesper, A. Schnitzler, P. Fischer, J. Hirschmann (Düsseldorf, Germany)

    Objective: Movement initiation and termination are often studied in isolation. Here we shed light on the neural processes underlying rapid changes of ongoing movements, where…
  • 2023 International Congress

    The development of a multiplex allele specific PCR to improve the diagnostic yield of NGS in the GBA gene screening

    C. Panteghini, C. Reale, I. Colangelo, M. Suerz, R. Cilia, R. Eleopra, B. Garavaglia, F. Invernizzi (Milano, Italy)

    Objective: Our aim is to offer a complete and reliable diagnostic service excluding false negative. Background: Heterozygous variants in the GBA gene are the most…
  • « Previous Page
  • 1
  • …
  • 94
  • 95
  • 96
  • 97
  • 98
  • …
  • 338
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • Screening and Treatment of Depression in Parkinson’s Disease within Movement Disorders Centers: A Quality Improvement Initiative
    • Yerba Mate (Ilex paraguaiensis) protects dopaminergic neurons degeneration and improve their maturation in culture
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley